Cynosure Management »

Alnylam Pharmaceuticals shares owned by Cynosure Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Cynosure Management from 13F filings

Historical chart of Cynosure Management investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Cynosure Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Cynosure Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $378k 950 397.65

More positions owned by Cynosure Management

Ishares Tr 0-3 Mnth Treasry (SGOV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Trust Ishare 0-1 (SHV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ge Healthcare Technologies I Common Stock (GEHC)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Circle Internet Group Com Cl A (CRCL)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Ultra Short Dur (ICSH)
Spdr Series Trust State Street Spd (SPYV)
Ishares Tr Core S&p Ttl Stk (ITOT)
Union Pacific Corporation (UNP)
International Business Machines (IBM)

View all positions for Cynosure Management

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
State Street Corporation
Geode Capital Management
Baillie Gifford & Co
Norges Bank Investment Management
Invesco
Dodge & Cox
Wellington Management Company
T. Rowe Price Investment Management
Orbis Allan Gray

View all funds holding Alnylam Pharmaceuticals